193 related articles for article (PubMed ID: 26506391)
1. Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers.
Hopp L; Nersisyan L; Löffler-Wirth H; Arakelyan A; Binder H
Genes (Basel); 2015 Oct; 6(4):1076-112. PubMed ID: 26506391
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Heterogeneity of B-Cell Lymphoma: DNA Methylation, Gene Expression and Chromatin States.
Hopp L; Löffler-Wirth H; Binder H
Genes (Basel); 2015 Sep; 6(3):812-40. PubMed ID: 26371046
[TBL] [Abstract][Full Text] [Related]
3. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
4. EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification.
Hemming S; Cakouros D; Isenmann S; Cooper L; Menicanin D; Zannettino A; Gronthos S
Stem Cells; 2014 Mar; 32(3):802-15. PubMed ID: 24123378
[TBL] [Abstract][Full Text] [Related]
5. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape.
Salminen A; Haapasalo A; Kauppinen A; Kaarniranta K; Soininen H; Hiltunen M
Prog Neurobiol; 2015 Aug; 131():1-20. PubMed ID: 26001589
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease.
Treviño LS; Wang Q; Walker CL
Prog Biophys Mol Biol; 2015 Jul; 118(1-2):8-13. PubMed ID: 25841987
[TBL] [Abstract][Full Text] [Related]
7. Functional coupling between writers, erasers and readers of histone and DNA methylation.
Torres IO; Fujimori DG
Curr Opin Struct Biol; 2015 Dec; 35():68-75. PubMed ID: 26496625
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies.
Serganova I; Chakraborty S; Yamshon S; Isshiki Y; Bucktrout R; Melnick A; Béguelin W; Zappasodi R
Front Cell Dev Biol; 2021; 9():805195. PubMed ID: 35071240
[TBL] [Abstract][Full Text] [Related]
9. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.
Agger K; Cloos PA; Christensen J; Pasini D; Rose S; Rappsilber J; Issaeva I; Canaani E; Salcini AE; Helin K
Nature; 2007 Oct; 449(7163):731-4. PubMed ID: 17713478
[TBL] [Abstract][Full Text] [Related]
10. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.
Lunning MA; Green MR
Blood Cancer J; 2015 Oct; 5(10):e361. PubMed ID: 26473533
[TBL] [Abstract][Full Text] [Related]
11. KIAA1718 is a histone demethylase that erases repressive histone methyl marks.
Yokoyama A; Okuno Y; Chikanishi T; Hashiba W; Sekine H; Fujiki R; Kato S
Genes Cells; 2010 Aug; 15(8):867-73. PubMed ID: 20629981
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
[TBL] [Abstract][Full Text] [Related]
13. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
14. Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism.
Escoubet-Lozach L; Lin IL; Jensen-Pergakes K; Brady HA; Gandhi AK; Schafer PH; Muller GW; Worland PJ; Chan KW; Verhelle D
Cancer Res; 2009 Sep; 69(18):7347-56. PubMed ID: 19738071
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Retinal Development via the Epigenetic Modification of Histone H3.
Watanabe S; Murakami A
Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Programing of B-Cell Lymphoma by BCL6 and Its Genetic Deregulation.
Yang H; Green MR
Front Cell Dev Biol; 2019; 7():272. PubMed ID: 31788471
[TBL] [Abstract][Full Text] [Related]
17. JMJD3 as an epigenetic regulator in development and disease.
Burchfield JS; Li Q; Wang HY; Wang RF
Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
[TBL] [Abstract][Full Text] [Related]
18. The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia.
Janczar S; Janczar K; Pastorczak A; Harb H; Paige AJ; Zalewska-Szewczyk B; Danilewicz M; Mlynarski W
Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28054944
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics and B-cell lymphoma.
Shaknovich R; Melnick A
Curr Opin Hematol; 2011 Jul; 18(4):293-9. PubMed ID: 21577103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
